secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001193125-26-183411
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZBH Q1 net sales $2.09B (+9.3% reported); adj EPS $2.09 (+15.5%); raises FY adj EPS guidance to $8.40-$8.55
--------------------------------------------------------------------------------

- Q1 net sales $2.087B, +9.3% reported, +6.8% constant currency, +2.9% organic constant currency.
- GAAP diluted EPS $1.22 (+34.1%); adjusted diluted EPS $2.09 (+15.5%).
- Operating cash flow $359.4M, free cash flow $245.9M in Q1.
- Repurchased $250M of shares during the first quarter.
- FY2026 adj EPS guidance raised to $8.40-$8.55 (from $8.30-$8.45); organic CC revenue guidance unchanged at 1-3%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/0001193125-26-183411-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/zbh-20260428.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-183411

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer